Owner Takeda Pharmaceutical Company Limited.

Inventors Tsukamoto, Tetsuya; Yamamoto, Shouzou; Goto, Mika; Shimojou, Masato; Kiyota, Yoshihiro; Setou, Masaki; Ohkawa, Shigenori

Agent Griffith Hack

Pub. Number AU-B-2004252005

PCT Pub. Number WO2005/000829

Priority 2003-182039 26.06.03 JP

Filing date 25 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 18 February 2010

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4178 (2006.01)

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/443 (2006.01)

A61K 31/453 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 307/86 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/54 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom